A Sad Message From Our Team. Loss of Our Co-founder Dr. Manfred Schmidt Read more
Unique therapies often warrant customized assays to adequately assess their safety. GeneWerkâs flexible assay development, qualification and validation services are not limited to our in-house developed assays.
We help develop, qualify and validate new or partially-developed assays for customers with unique requirements.
We work closely with our clients often acting as an extension of their internal technical teams. From customization of proven assays to new biomarker assay development, we provide best-in-class services to address specific regulatory needs for emerging gene therapies.
Our highly experienced and interdisciplinary team has been developing and validating assays for over two decades to tackle complex safety issues such as the investigation of severe adverse events (SAEs) during clinical development.
Consult with our experts about solutions to your biosafety challenges.
Read our latest press releases and announcements below.